These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 833761)

  • 21. Selective inhibition of warfarin metabolism by diltiazem in humans.
    Abernethy DR; Kaminsky LS; Dickinson TH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):411-5. PubMed ID: 2020000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
    Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND
    Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of blood sampling schedules on protein drug binding in the rat.
    Hulse M; Feldman S; Bruckner JV
    J Pharmacol Exp Ther; 1981 Aug; 218(2):416-20. PubMed ID: 6166741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of tumor growth in adult rats in vivo during an acute fast.
    Sauer LA; Nagel WO; Dauchy RT; Miceli LA; Austin JE
    Cancer Res; 1986 Jul; 46(7):3469-75. PubMed ID: 3708579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of fasting on the diuretic response and disposition of furosemide in rats.
    Chakrabarti SK; Brodeur J
    Can J Physiol Pharmacol; 1980 Feb; 58(2):205-11. PubMed ID: 7378922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inability of accumulated metabolic byproducts of uremia to alter the extent of warfarin binding in charcoal treated plasma.
    Bachmann K; Conway P; Shapiro R
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):117-30. PubMed ID: 663394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of furosemide on plasma clearance, anticoagulant effect and protein binding of warfarin in rats.
    Ogiso T; Iwaki M; Konishi Y
    J Pharmacobiodyn; 1982 Oct; 5(10):829-40. PubMed ID: 7161710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of lipophilicity in the extrahepatic disposition of aminostilbene derivatives following administration to rat.
    Schenk J; Neumann HG
    Xenobiotica; 1980 Sep; 10(9):675-88. PubMed ID: 7445529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary excretion of warfarin in rabbits: relationship between pharmacological effect and salivary pharmacokinetics of warfarin in rabbits.
    Sakai K; Nishiura A; Fujihara Y; Kutsuna T; Nishino T
    J Pharmacobiodyn; 1983 Dec; 6(12):991-9. PubMed ID: 6674482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of hepatic uptake on the disappearance of warfarin from the plasma of rats: a kinetic analysis.
    Covell DG; Abbrecht PH; Berman M
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):127-45. PubMed ID: 6886970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics of coumarin anticoagulants XXV: Warfarin-ibuprofen interaction in rats.
    Slattery JT; Yacobi A; Levy G
    J Pharm Sci; 1977 Jul; 66(7):943-7. PubMed ID: 886455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosis.
    Wang JP; Unadkat JD; McNamara S; O'Sullivan TA; Smith AL; Trager WF; Ramsey B
    Clin Pharmacol Ther; 1994 May; 55(5):528-34. PubMed ID: 8181197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue binding of warfarin.
    Conway P; Valentovic M; Bachmann K
    Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):309-15. PubMed ID: 523773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sodium salicylate on the fate of warfarin in the rat.
    Coldwell BB; Buttar HS; Paul CJ; Thomas BH
    Toxicol Appl Pharmacol; 1974 Jun; 28(3):374-84. PubMed ID: 4851695
    [No Abstract]   [Full Text] [Related]  

  • 39. Age-dependent changes in warfarin tissue distribution.
    Kato Y; Hirate J; Sakaguchi K; Ueno M; Horikoshi I
    J Pharmacobiodyn; 1986 Nov; 9(11):889-95. PubMed ID: 3559879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of coumarin anticoagulants XLIV: Dose-dependent pharmacokinetics of warfarin in rats.
    Takada K; Levy G
    J Pharm Sci; 1980 Jan; 69(1):9-14. PubMed ID: 7354452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.